MedTrace Logo

A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects

NCT03945149 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-12-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the safety and tolerance of Turmipure Gold™ product during a chronic consumption of 5 weeks in healthy subjects. The hypothesis of this study is that there are no alterations of the gastrointestinal tolerance, of the haematological and biochemical profiles due to Turmipure Gold™ consumption compared to placebo.

Conditions

  • Gastrointestinal Tolerance
  • Liver Function
  • Kidney Function

Interventions

DIETARY_SUPPLEMENT

Turmipure Gold™

30 subjects will take 1000mg in 4 capsules (with 250ml water before breakfast , each day, during 5 weeks

DIETARY_SUPPLEMENT

Placebo

30 subjects will take 4 capsules with 250ml water before breakfast , each day, during 5 weeks

Sponsors & Collaborators

  • BioFortis

    collaborator OTHER

  • Givaudan France Naturals

    lead INDUSTRY

Principal Investigators

  • Pascale Fança-Berthon, PhD · Naturex

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2019-07-26
Completion
2019-07-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03945149 on ClinicalTrials.gov